Neurology News

Biotech company PharmaJet announced that its partner, the Institute for Molecular Medicine, was awarded a $12 million grant from the NIH National Institute on Aging for a vaccine to prevent Alzheimer’s disease.

Age variability in symptom onset of Alzheimer’s disease in those with Down syndrome was comparable to those who experienced autosomal dominant AD, while mortality was also similar, according to a study published in JAMA Network Open.

Presence of axonal phosphorylated transactive response DNA-binding protein 43, or pTDP-43, accumulation in intramuscular nerve bundles is a likely biomarker for patients diagnosed with ALS, according to a study published in JAMA Neurology.

One in four neurosurgery patients experience adverse events, of which 25% are attributable to human error, according to a study published in Brain and Spine.

Onset of seizures after stroke more than doubled the risk for dementia in young patients, according to a study published in Neurology.

Lacosamide monotherapy for the treatment of childhood epilepsy with centrotemporal spikes was well tolerated and resulted in significantly reduced seizures, according to a study published in Brain and Development.

Biopharmaceutical company AbbVie has submitted a new drug application to the FDA for ABBV-951, a 24-hour subcutaneous treatment for motor fluctuations in patients with advanced Parkinson's disease.

Patients with young-onset dementia are at greater risk for hospitalization due to motor vehicle crash injury than those without dementia, according to a study published in JAMA Network Open.

The introduction of a multifaceted educational campaign was associated with significant improvements in ambulance use and hospital arrival times for patients with stroke, according to a study published in JAMA Network Open.

Relapsing MS patients, as well as those with disability progression independent of relapse activity, experienced increased brain atrophy, specifically in the cerebral cortex, researchers reported in JAMA Neurology.